- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 7 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 7 residues within 4Å:- Chain A: D.331, Q.429, L.430, P.431, D.432
- Chain C: P.218
- Chain G: F.4
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:L.430, A:D.432
PO4.12: 2 residues within 4Å:- Chain D: G.121, E.123
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:G.121
- Salt bridges: D:R.190
PO4.16: 5 residues within 4Å:- Chain E: R.15, P.16, E.17
- Chain G: R.24
- Ligands: PO4.21
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.17
PO4.19: 2 residues within 4Å:- Chain F: P.41, Y.83
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:Y.83
PO4.21: 4 residues within 4Å:- Chain G: R.24, A.25, F.26
- Ligands: PO4.16
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:A.25, G:F.26, G:F.26
PO4.22: 5 residues within 4Å:- Chain G: F.26, H.28, Y.29, F.30, S.31
6 PLIP interactions:6 interactions with chain G- Hydrogen bonds: G:H.28, G:H.28, G:Y.29, G:F.30, G:S.31, G:S.31
PO4.23: 3 residues within 4Å:- Chain G: A.43, L.46, R.47
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:A.43
- Salt bridges: G:R.47
- 5 x CDL: CARDIOLIPIN(Non-covalent)
CDL.3: 10 residues within 4Å:- Chain A: F.335, F.441, W.442, L.443, R.444
- Chain C: R.4, F.17, I.18, H.220
- Ligands: 6PE.1
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain A- Salt bridges: C:R.4, C:H.220, A:R.444
- Hydrogen bonds: A:L.443
CDL.8: 11 residues within 4Å:- Chain C: S.27, S.28, W.29, M.95
- Chain F: Q.62
- Chain G: V.37, R.40, T.41, C.44
- Ligands: PEE.9, CDL.13
7 PLIP interactions:2 interactions with chain C, 2 interactions with chain F, 3 interactions with chain G- Hydrogen bonds: C:S.28, C:S.28, F:Q.62, F:Q.62
- Salt bridges: G:R.40, G:R.40, G:R.40
CDL.13: 20 residues within 4Å:- Chain C: S.28, L.35, K.226, L.229, G.230, L.233, L.234
- Chain D: Y.219, K.222, R.223, K.230
- Chain F: R.61
- Chain G: Y.29, F.30, G.33, I.34, N.36, V.37, R.40
- Ligands: CDL.8
12 PLIP interactions:3 interactions with chain C, 6 interactions with chain D, 3 interactions with chain G- Hydrophobic interactions: C:L.233, D:Y.219, G:I.34
- Hydrogen bonds: C:N.31, D:K.230, D:K.230, G:N.36
- Salt bridges: C:K.226, D:K.222, D:R.223, D:K.230, G:R.40
CDL.18: 5 residues within 4Å:- Chain E: K.52, S.56, V.59, S.60, S.63
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:S.56, E:S.56
- Salt bridges: E:K.52, E:K.52
CDL.20: 2 residues within 4Å:- Chain D: H.120
- Chain G: Y.59
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:H.120
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.4: 25 residues within 4Å:- Chain C: L.40, Q.43, I.44, G.47, L.48, L.50, A.51, Y.54, R.79, H.82, A.83, A.86, F.89, T.125, A.126, G.129, Y.130, L.132, P.133, F.178, H.181, F.182, P.185, E.270, Y.272
20 PLIP interactions:20 interactions with chain C,- Hydrophobic interactions: C:L.40, C:Q.43, C:I.44, C:L.50, C:Y.54, C:A.83, C:A.86, C:F.89, C:T.125, C:A.126, C:L.132, C:L.132, C:F.178, C:F.182, C:F.182
- Salt bridges: C:R.79, C:R.79
- pi-Stacking: C:H.181
- Metal complexes: C:H.82, C:H.181
HEM.5: 23 residues within 4Å:- Chain C: W.30, G.33, S.34, L.36, G.37, L.93, H.96, V.97, R.99, S.105, F.108, T.111, W.112, G.115, V.116, L.118, L.119, H.195, L.196, L.199, S.204, N.205
- Ligands: JGW.10
21 PLIP interactions:21 interactions with chain C,- Hydrophobic interactions: C:L.36, C:L.36, C:V.97, C:T.111, C:W.112, C:W.112, C:L.119, C:L.196, C:L.199, C:L.199
- Hydrogen bonds: C:G.33, C:S.105, C:S.204, C:N.205
- Water bridges: C:F.32
- Salt bridges: C:H.96, C:R.99, C:R.99
- pi-Cation interactions: C:R.99
- Metal complexes: C:H.96, C:H.195
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.9: 17 residues within 4Å:- Chain C: W.29, Y.94, M.95, G.98, R.99, Y.102, Y.103, M.315, Q.321, F.324, W.325, V.328, L.331
- Chain F: Q.62
- Chain G: C.44, V.48
- Ligands: CDL.8
15 PLIP interactions:14 interactions with chain C, 1 interactions with chain F- Hydrophobic interactions: C:W.29, C:W.29, C:W.29, C:Y.102, C:Y.102, C:Y.103, C:F.324, C:W.325, C:W.325, C:V.328, C:L.331
- Hydrogen bonds: C:Y.102, C:Y.102, C:Q.321, F:Q.62
PEE.17: 16 residues within 4Å:- Chain C: I.77, I.235, M.239
- Chain D: H.199, M.203, K.206, M.207, M.210, M.211
- Chain E: Y.49, A.50, A.51, N.53, V.54, Q.57
- Chain J: D.35
7 PLIP interactions:3 interactions with chain D, 3 interactions with chain E, 1 interactions with chain J- Hydrophobic interactions: D:M.210, E:Y.49, E:V.54
- Salt bridges: D:H.199, D:K.206
- Hydrogen bonds: E:Q.57, J:D.35
- 1 x JGW: 2-methyl-3-[4-[[4-(trifluoromethyloxy)phenyl]methyl]phenyl]-3~{H}-quinolin-4-one(Non-covalent)
- 1 x HEC: HEME C(Non-covalent)
HEC.11: 21 residues within 4Å:- Chain D: V.31, V.35, C.36, C.39, H.40, N.104, A.107, L.108, P.109, P.110, L.112, I.115, R.119, Y.125, L.129, L.130, F.152, I.157, G.158, M.159, P.162
16 PLIP interactions:16 interactions with chain D,- Hydrophobic interactions: D:V.31, D:V.35, D:N.104, D:A.107, D:P.109, D:P.110, D:L.112, D:I.115, D:L.129, D:L.130, D:P.162
- Hydrogen bonds: D:Y.125, D:Y.125, D:G.158
- Salt bridges: D:R.119
- Metal complexes: D:H.40
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.15: 16 residues within 4Å:- Chain A: Y.415, D.416, F.441, L.443
- Chain D: M.221
- Chain E: Y.37, T.40, T.44, V.47
- Chain J: F.13, R.14, T.16, F.19, A.20, I.23
- Ligands: 6PE.1
8 PLIP interactions:2 interactions with chain A, 3 interactions with chain E, 3 interactions with chain J- Salt bridges: A:D.416
- pi-Cation interactions: A:F.441, E:Y.37, J:F.19
- Hydrophobic interactions: E:V.47, J:A.20, J:I.23
- Hydrogen bonds: E:T.40
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the ubiquinol-reduction (Qi) site of the mitochondrial cytochrome bc1 complex for the development of next generation quinolone antimalarials. To Be Published
- Release Date
- 2021-06-30
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 7 x PO4: PHOSPHATE ION(Non-functional Binders)
- 5 x CDL: CARDIOLIPIN(Non-covalent)
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 1 x JGW: 2-methyl-3-[4-[[4-(trifluoromethyloxy)phenyl]methyl]phenyl]-3~{H}-quinolin-4-one(Non-covalent)
- 1 x HEC: HEME C(Non-covalent)
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the ubiquinol-reduction (Qi) site of the mitochondrial cytochrome bc1 complex for the development of next generation quinolone antimalarials. To Be Published
- Release Date
- 2021-06-30
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.